ATRIA
发表于 2025-3-26 22:13:24
http://reply.papertrans.cn/48/4731/473014/473014_31.png
疯狂
发表于 2025-3-27 02:57:17
Infarct Size Reduction by Antiarrhythmic Prophylaxis — A Contrary Viewl extent of irreversible damage. Although limitation of infarct size has a reasonable basis in animal experimentation. there is a paucity of evidence that meaningful infarct size limitation can be achieved in man.
SLAY
发表于 2025-3-27 05:41:53
http://reply.papertrans.cn/48/4731/473014/473014_33.png
Embolic-Stroke
发表于 2025-3-27 12:36:23
http://reply.papertrans.cn/48/4731/473014/473014_34.png
包裹
发表于 2025-3-27 16:48:09
http://reply.papertrans.cn/48/4731/473014/473014_35.png
受辱
发表于 2025-3-27 17:47:08
http://reply.papertrans.cn/48/4731/473014/473014_36.png
Galactogogue
发表于 2025-3-27 22:46:00
Book 1984lence of this syndrome has been decreasing in the United States, still over 1.5 million patients develop myocardial infarction per year. There is about a 20% chance of a North American male developing myocardial in farction before the age of 65. The in-hospital mortality still remains at ap proxim
高深莫测
发表于 2025-3-28 05:52:23
The Case for Prophylactic Lidocaine in Acute Myocardial Infarctionveloped (9–11). In addition, lidocaine had been proposed for pre-hospital administration to prevent sudden death in patients experiencing myocardial infarction during transport to the hospital (12, 13).
Acetaldehyde
发表于 2025-3-28 08:47:51
http://reply.papertrans.cn/48/4731/473014/473014_39.png
争论
发表于 2025-3-28 14:23:45
0166-9842 participants to express their own viewpoints leading to a consensus opinion. The first part of this Symposium addresses the models of experimental myocardial in978-1-4613-3821-5978-1-4613-3819-2Series ISSN 0166-9842